BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38801095)

  • 1. Related mechanisms, current treatments, and new perspectives in meningioma.
    Inetas-Yengin G; Bayrak OF
    Genes Chromosomes Cancer; 2024 May; 63(5):e23248. PubMed ID: 38801095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Atypical and Anaplastic Meningiomas.
    Buttrick S; Shah AH; Komotar RJ; Ivan ME
    Neurosurg Clin N Am; 2016 Apr; 27(2):239-47. PubMed ID: 27012388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic landscape of intracranial meningiomas.
    Bi WL; Abedalthagafi M; Horowitz P; Agarwalla PK; Mei Y; Aizer AA; Brewster R; Dunn GP; Al-Mefty O; Alexander BM; Santagata S; Beroukhim R; Dunn IF
    J Neurosurg; 2016 Sep; 125(3):525-35. PubMed ID: 26771848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options.
    Qin C; Huang M; Pan Y; Li Y; Long W; Liu Q
    Brain Tumor Pathol; 2021 Jul; 38(3):156-172. PubMed ID: 33903981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatment options for meningioma.
    Apra C; Peyre M; Kalamarides M
    Expert Rev Neurother; 2018 Mar; 18(3):241-249. PubMed ID: 29338455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MOLECULAR PATHOLOGY OF MENINGIOMAS].
    Murnyák B; Csonka T; Hortobágyi T
    Ideggyogy Sz; 2015 Sep; 68(9-10):292-300. PubMed ID: 26665490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.
    Choy W; Kim W; Nagasawa D; Stramotas S; Yew A; Gopen Q; Parsa AT; Yang I
    Neurosurg Focus; 2011 May; 30(5):E6. PubMed ID: 21529177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current experimental therapies for atypical and malignant meningiomas.
    Corona AM; Di L; Shah AH; Crespo R; Eichberg DG; Lu VM; Luther EM; Komotar RJ; Ivan ME
    J Neurooncol; 2021 Jun; 153(2):203-210. PubMed ID: 33950341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards Molecular Classification of Meningioma: Evolving Treatment and Diagnostic Paradigms.
    Proctor DT; Ramachandran S; Lama S; Sutherland GR
    World Neurosurg; 2018 Nov; 119():366-373. PubMed ID: 30138732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular alterations in meningioma: prognostic and therapeutic perspectives.
    Birzu C; Peyre M; Sahm F
    Curr Opin Oncol; 2020 Nov; 32(6):613-622. PubMed ID: 32890025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningiomas and neurofibromatosis for the oncologist.
    Schrell UM; Fahlbusch R; Adams EF
    Curr Opin Oncol; 1994 May; 6(3):247-53. PubMed ID: 8080853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current standing and frontiers of gene therapy for meningiomas.
    De La Garza-Ramos R; Flores-Rodríguez JV; Martínez-Gutiérrez JC; Ruiz-Valls A; Caro-Osorio E
    Neurosurg Focus; 2013 Dec; 35(6):E4. PubMed ID: 24289129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas.
    Cordova C; Kurz SC
    Curr Oncol Rep; 2020 Jul; 22(8):84. PubMed ID: 32617743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathogenesis of meningiomas.
    Perry A; Gutmann DH; Reifenberger G
    J Neurooncol; 2004 Nov; 70(2):183-202. PubMed ID: 15674477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningiomas: Overview and New Directions in Therapy.
    Wang N; Osswald M
    Semin Neurol; 2018 Feb; 38(1):112-120. PubMed ID: 29548058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of pediatric CNS meningiomas: CCHE-57357 experience in 39 cases.
    El Beltagy MA; Enayet AE; Atteya MME; Reda M; Refaat A; Taha H; Ahmed S; Abdelaziz A
    Childs Nerv Syst; 2019 Aug; 35(8):1323-1331. PubMed ID: 31127346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas.
    Sioka C; Kyritsis AP
    J Neurooncol; 2009 Mar; 92(1):1-6. PubMed ID: 19023520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear cell meningiomas: three case reports with genetic characterization and review of the literature.
    Ohba S; Sasaki H; Kimura T; Ikeda E; Kawase T
    Neurosurgery; 2010 Sep; 67(3):E870-1; discussion E871. PubMed ID: 20683214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningiomas in 2009: controversies and future challenges.
    Campbell BA; Jhamb A; Maguire JA; Toyota B; Ma R
    Am J Clin Oncol; 2009 Feb; 32(1):73-85. PubMed ID: 19194129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.